Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96686883 | 9668688 | 3 | F | 20160819 | 20131105 | 20160829 | PER | US-ELI_LILLY_AND_COMPANY-US201310008472 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96686883 | 9668688 | 1 | PS | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Transplacental | 10 MG, QD | U | U | 18936 | 10 | MG | QD | |||||
| 96686883 | 9668688 | 2 | SS | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Transplacental | 20 MG, QD | U | U | 18936 | 20 | MG | QD | |||||
| 96686883 | 9668688 | 3 | SS | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Transplacental | 40 MG, QD | U | U | 18936 | 40 | MG | QD | |||||
| 96686883 | 9668688 | 4 | C | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Transplacental | 80 MG, EACH EVENING | U | 0 | 80 | MG | QD | ||||||
| 96686883 | 9668688 | 5 | C | ZYPREXA | OLANZAPINE | 1 | Transplacental | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 96686883 | 9668688 | 6 | C | XANAX | ALPRAZOLAM | 1 | Transplacental | 1 MG, BID | U | 0 | 1 | MG | BID | ||||||
| 96686883 | 9668688 | 7 | C | XANAX | ALPRAZOLAM | 1 | Transplacental | 1 MG, TID | U | 0 | 1 | MG | TID | ||||||
| 96686883 | 9668688 | 8 | C | XANAX | ALPRAZOLAM | 1 | Transplacental | 1 MG, QID | U | 0 | 1 | MG | QID | ||||||
| 96686883 | 9668688 | 9 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Transplacental | 150 MG, QD | U | 0 | 150 | MG | QD | ||||||
| 96686883 | 9668688 | 10 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Transplacental | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 96686883 | 9668688 | 11 | C | PRENATAL /00231801/ | VITAMINS | 1 | Transplacental | 1 DF, QD | U | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96686883 | 9668688 | 1 | Depression |
| 96686883 | 9668688 | 4 | Mood altered |
| 96686883 | 9668688 | 6 | Panic disorder |
| 96686883 | 9668688 | 9 | Depression |
| 96686883 | 9668688 | 11 | Pregnancy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96686883 | 9668688 | CA |
| 96686883 | 9668688 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96686883 | 9668688 | Atrial septal defect | |
| 96686883 | 9668688 | Foetal exposure during pregnancy | |
| 96686883 | 9668688 | Ventricular septal defect |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96686883 | 9668688 | 1 | 20051020 | 20051023 | 0 | |
| 96686883 | 9668688 | 2 | 20051024 | 20051027 | 0 | |
| 96686883 | 9668688 | 3 | 20051028 | 0 | ||
| 96686883 | 9668688 | 11 | 20051020 | 0 |